Onzigolide
As of the edition of 20 October 2026, Onzigolide is a drug: stopped in 2011; acts on DRD2, SSTR2 and SSTR5.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Stopped, 2011
- Kind
- Unknown
- Registered trials
- 2, 2 stopped early
- Disease areas
- Bones, joints and muscles; Chemically induced; Hormones; Nervous system
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 2 | 2 | 0 | 0 | 2 |
| All trials | 2 |